Historically, because of the random nature of the nucleation process, lyophilization has been difficult to control. For a typical pharmaceutical formulation filled in vials, for example, crystals might form at temperatures ranging from –5 to –20 °C).
As the nucleation temperature has a direct impact on the developing ice structure and crystal size — as well as the appearance of the dried product cake — it can negatively influence the product’s critical quality attributes (CQAs), such as residual moisture or dissolution behavior.
A new patent-pending technology from GEA, which is fully compatible with all our currently available freeze dryers, provides a novel and scalable method to control the nucleation process without having to develop new pharmaceutical formulations.
Process without LYOSPARK®
Simultaneous Crystal Nucleation
LYOSPARK® enables the user to control the temperature at which nucleation crystals form inside the product, thereby ensuring that, at any time, every vial in the chamber is subjected to the same process conditions, irrespective its specific location on the shelf.Combining LYOSPARK® technology with conventional freeze-drying processes is very simple. The vials are loaded into the freeze dryer as usual and cooled to the optimal (product dependent) nucleation temperature. As soon as the nucleation temperature is reached, the chamber is vented with gas from a condenser.
A filter-equipped cooling trap is mounted on the chamber. Ice crystals form on the cooled surface of the trap and are entrained in the gas stream during venting. Inside the supercooled product solution, the ice crystals undergo immediate and homogenous nucleation in each vial.
As the formation of ice crystals at higher temperatures results in larger pores, drying times can be shortened. Furthermore, LYOSPARK® offers better scalability, sterility and higher throughput speeds than conventional systems, resulting in optimized performance and productivity.
Process with LYOSPARK®
Process Optimization
LYOSPARK®, which eliminates issues such as the denaturation of active ingredients or unpredictable scale-up, also provides several technical advantages, including improved product quality, better vial uniformity per batch and a more homogenous, aesthetically pleasing cake.In summary, LYOSPARK® controlled nucleation technology facilitates uniform ice crystal formation in laboratory and production-scale freeze dryers with a minimum degree of supercooling. This is reflected in more consistent and larger ice crystal sizes with a more open product structure. As a result, faster drying and reconstitution times can be achieved.
QbD-compliant, GEA’s LYOSPARK® delivers a more uniform, higher quality product, reduces process times and provides a cost-effective solution to controlled nucleation.
At a glance advantages
- Larger ice crystals
- Shorter drying times
- Better process control
- Better reconstitution
- Less vial cracking
- Less stress on biological agents
- Better looking cake
This cost-efficient technology will be offered as an option for all GEA freeze dryers and will also be available as a retrofit option for existing plant.
Downloads
Produits associés
LYOVAC® Pharma Freeze Dryer
GEA’s LYOVAC® industrial-scale freeze dryers are built to customer specifications and are available with production areas of 1–60 m² and condenser capacities of more than 1000 kg.
LYOVAC® Freeze dryers for small scale production modules
LYOVAC® Freeze dryers for small scale production modules
LYOVAC® Small-Scale Freeze Dryers
Extending its range of LYOVAC™ Freeze Dryers, GEA now offers both integrated and standalone equipment for the production of small-scale batches and formulation or process development.
GEA Insights
La percée qui a révolutionné le séchage par atomisation
En 1976, les ingénieurs de NIRO répondaient à un défi concurrentiel en repensant ce que pouvait faire le séchage par atomisation. Leur idée est à l'origine du sécheur-atomiseur à plusieurs étages MSD. Cinquante ans plus tard, ce même principe fondamental aide à transformer les liquides en poudres, qui sont utilisées dans des produits nutritionnels essentiels et des médicaments importants partout dans le monde. Perfectionné au cours de plusieurs décennies d'expertise technique, d'enquêtes clientèle et de développement continu, le MSD est une histoire d'innovation aux retombées durables.
Au-delà des machines : exploiter les gisements de performance des installations
Ce n'est pas parce que vous avez des machines efficaces que votre usine l'est. Une trajectoire d'amélioration efficace commence souvent par une analyse qui ne se limite pas aux équipements pris individuellement, et cherche à comprendre comment les processus, les systèmes énergétiques et les décisions opérationnelles s'influencent mutuellement. C'est une démarche holistique, conçue pour repérer des opportunités qui, sans cela, risqueraient de passer inaperçues.
Comment une vanne révolutionne la production des aliments et des boissons
Dans les installations agroalimentaires, les vannes sont généralement actionnées en utilisant de l'air comprimé. La technologie d'actionnement GEA Hydract® Actuation Technology, quant à elle, actionne les vannes en utilisant de l'eau, au sein d'un circuit fermé à commande numérique. Résultat, une vanne peut être maintenue en place de manière exacte et réglée par petits paliers. Cela se traduit par une consommation d'énergie en baisse et un meilleur contrôle.
